Multiple Assemblies exist for SMTL entry 5tzc
Crystal Structure of human PDE2a in complex with (5S)-1-[(3-bromo-4-fluorophenyl)carbonyl]-3,3-difluoro-5-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine; X-RAY DIFFRACTION 2.36 Å

	SMTL ID 5tzc.1 Ligands (3-bromo-4-fluorophenyl)[(5S)-3,3-difluoro-5-(5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperidin-1-yl]methanone; ZINC ION; MAGNESIUM ION Polypeptides cGMP-dependent 3',5'-cyclic phosphodiesterase Oligo-state monomer
	SMTL ID 5tzc.2 Ligands (3-bromo-4-fluorophenyl)[(5S)-3,3-difluoro-5-(5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperidin-1-yl]methanone; ZINC ION; MAGNESIUM ION Polypeptides cGMP-dependent 3',5'-cyclic phosphodiesterase Oligo-state monomer
	SMTL ID 5tzc.3 Ligands (3-bromo-4-fluorophenyl)[(5S)-3,3-difluoro-5-(5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperidin-1-yl]methanone; ZINC ION; MAGNESIUM ION Polypeptides cGMP-dependent 3',5'-cyclic phosphodiesterase Oligo-state monomer
	SMTL ID 5tzc.4 Ligands (3-bromo-4-fluorophenyl)[(5S)-3,3-difluoro-5-(5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperidin-1-yl]methanone; ZINC ION; MAGNESIUM ION Polypeptides cGMP-dependent 3',5'-cyclic phosphodiesterase Oligo-state monomer